Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.
about
Pulmonary complications of sickle cell disease.Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factorExercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.Peroxisome proliferator-activated receptor-α-mediated transcription of miR-199a2 attenuates endothelin-1 expression via hypoxia-inducible factor-1αSevere painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study.Vasculopathy and pulmonary hypertension in sickle cell disease.Pathophysiology and treatment of pulmonary hypertension in sickle cell diseaseReview: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension.Cardiovascular abnormalities in sickle cell disease.Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.Bosentan for the treatment of adult pulmonary hypertension.Pulmonary hypertension in children with sickle cell disease.Novel therapies targeting the endothelium in sickle cell disease.Chronic Pulmonary Complications of Sickle Cell Disease.Pulmonary hypertension associated with thalassemia syndromes.Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia.Pulmonary hypertension in hemolytic anemiasEndothelin-Type A receptors mediate pain in a mouse model of sickle cell disease.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.
P2860
Q30515769-45D90C27-1A71-4C9E-A86B-CC28E17F12E7Q33899415-CE876A9E-AACC-4B15-987F-07D46BFA88E5Q34019609-892931C0-9E14-45A5-A3E9-D72A25C70BEEQ34038886-3B9EC65B-A764-4F51-93FD-EF9F4A771473Q34774521-CD6CFC61-12A7-4831-A0DC-C4F6A603A028Q35041547-4CB93F8C-E8F6-4D70-B58C-01AC33ED084EQ35086394-22F8CD1F-CAD5-4248-B86A-45781B0EEF79Q36596861-BB1592A0-EE91-4479-B4B2-F6321828565EQ37354098-CD12B04B-94F7-409E-B90B-93E6904FB2FDQ37435068-C19EB57A-8079-4566-91BC-196FB464DC4AQ37565002-E19C6150-9912-433B-B67B-CA0AD4288390Q37698249-68584520-3F39-4475-9570-FC1C4A6FEBD8Q37822722-E521E5A7-F545-41AD-A5DF-999BBC53E0EAQ37867674-8F7662C1-84C4-49E2-866C-B37B2CD7994DQ37930655-BE55D6DE-5547-4A46-9286-40228EC2290EQ38719970-CD469C2D-C827-46DA-9287-AC2DBD8F5D69Q38786355-9FFCE517-0BF0-4231-B675-C94FDB4A4500Q38799393-A2D568EC-3A66-42BA-A90B-21CD31A5A9EDQ39269713-05C4AE55-9DF0-4337-869F-D62434C3E227Q41975944-1BEAEB14-B11C-45DB-B4D0-6C02C81C0E15Q42415504-F1C057DA-EDE8-4345-A10D-DADF798828A9Q52653304-79C8397E-A147-4EAA-BC96-23B170F45FD1Q55427971-87588EE8-7C7A-45F5-BEE0-48D95E3EC526
P2860
Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Endothelin receptor antagonist ...... ents with sickle cell disease.
@ast
Endothelin receptor antagonist ...... ents with sickle cell disease.
@en
type
label
Endothelin receptor antagonist ...... ents with sickle cell disease.
@ast
Endothelin receptor antagonist ...... ents with sickle cell disease.
@en
prefLabel
Endothelin receptor antagonist ...... ents with sickle cell disease.
@ast
Endothelin receptor antagonist ...... ents with sickle cell disease.
@en
P2093
P2860
P1476
Endothelin receptor antagonist ...... ents with sickle cell disease.
@en
P2093
Caterina P Minniti
Roberto F Machado
Vandana Sachdev
Wynona A Coles
P2860
P304
P356
10.1111/J.1365-2141.2009.07906.X
P407
P577
2009-09-22T00:00:00Z